Corporate Responsibility Report

Overview

The report describes Endo's 2020 response to COVID-19, including continued medicine delivery, support for team members, and fill-finish manufacturing for Novavax's vaccine candidate. It documents a materiality assessment, Board and committee oversight of ESG, and the launch of a DE&I strategy led by a Global Head and Leadership Council. Environmental highlights include a 46% increase in recycled materials to 345 tons and reductions in hazardous and non-hazardous waste.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2020
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services